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The Baltimore-Washington Infant Study, an epidemiologic 
investigation of congenital heart disease, searches for ge- 
netic and environmental risk factors. Among 2,102 infsnts 
with heart disease, 17.5% had a noncardiac abnormality of 
chromosomal or genetic origin, whereas among 2,328 con- 
trol infants, only 0.7% had a genetic abnormality. 
Familial cardiovascular malformations encountered can 
be grouped into five distinct etiologic mechanisms. Single 
gene effects may be responsible for the specific histologic 
and biochemical changes in familial atrial septal defect with 
conduction disturbance and also in idiopathic ventricular 
hypertrophy. Left heart lesions showed familial concor- 
dance by the presumed morphogenetic mechanism of ab- 
normal embryonic blood flow with phenotypes of varying 
severity. pulmonary stenosis appeared with familial herita- 
ble disorders, as well as a partially concordant lesion with 
Population-based epidemiologic studies have achieved re- 
markable success in adult cardiology with the recognition of 
elevated serum cholesterol, smoking and hypertension as 
risk factors for coronary heart disease. Assessment of the 
differential strengths of genetic and environmental determi- 
nants of these risks made possible the design of preventive 
intervention trials. 
Pediatric cardiology has not had a comparable sequence 
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tetralogy of Fallot. Ventricular septal defect with trauspo- 
sition of the great arteries (one sibling pair) and with 
truncus arteriosus (two sibling pairs) indicate forme fruste 
expression of conotruncal defects. Endocardial cushion de- 
fect occurred with and without Down’s syndrome in mem- 
bers of three families, suggesting inheritance of a defect 
affecting cellular migration. Heritable blood coagulopathies 
occurred in case families and not in control families. The 
association of hemophilia and transposition, observed also by 
others, is extremely unlikely by chance and suggests genetic 
errors of endothelial cell function. 
The description of specific families from a population- 
based study emphasizes biologic questions on the nature of 
the inheritance of cardiovascular malformations. 
(_I Am Co11 Cardiol1989;14:?56-43) 
of studies of risk factors for cardiovascular malformations. 
In fact, not a single descriptive study had defined differences 
between case and control families at the time when a 
proposed hypothesis of an etiologic role of gestational hor- 
mone therapy captured professional and societal interest 
(1,2). Our epidemiologic investigation of maternal hormone 
therapy (3) made obvious the need to delineate confounding 
factors for which adjustments should be made before a 
meaningful evaluation of a potentially harmful single agent 
could be achieved. 
The Baltimore-Washington Infant Study was designed as 
an exploratory case-control study to provide comparative 
genetic and environmental data on the families of infants 
with cardiovascular malformations and the families of con- 
trol infants representing the birth cohort. Searching for 
evidence of genetic susceptibility to congenital heart dis- 
ease, this study describes observations on 2,102 case infants 
and on 2,328 control infants and presents new questions 
regarding the nature of the inherited risk factors. Questions 
are raised about the heritable biologic factors that might 
account for the familial abnormalities. 
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Table 1. Genetic Abnormalities in Case and Control Families 
With noncardiac abnormality 
Genetic 
Chromosome abnormality 
Syndromeheritable disorder 
Potentially geneticicnvironmcntal 
Suspect syndrome 
Nonsyndromic 
Withoul noncardiac abnormality 
Cases Controls 
(n = 2,102) (n = 2,328) 
NO. ‘Z NO. Q 
563 26.8 84 3.6 
271 12.9 1 III 
96 4.6 15 0.6 
20 1.0 0 - 
174 8.3 67 2.‘) 
I539 73.2 2244 %.4 
(“Isolated”) (Normal) 
Methods 
The Baltimore-Washington Infant Study is an ongoing 
case-control study of cardiovascular malformations in a 
defined geographic area of 90,000 annual births (Maryland. 
District of Columbia and Northern Virginia). The study, 
initiated on January 1, 1981, has been previously described 
(4,5). Cases are infants <1 year of age in whom the diagnosis 
of a cardiovascular malformation has been confirmed by 
echocardiography, cardiac catheterization. surgery or au- 
topsy, excluding only infants of <3X weeks’ gestation with 
patent ductus arteriosus. Cases are ascertained by the pedi- 
atric cardiology centers of the region and by searches of 
pathology records in 53 area hospitals. A review of death 
certificates validates this case ascertainment. A sample of 
control infants is chosen by computer algorithm to bc 
representative of the birth cohort. 
Cardiac malformations are coded according to the Inter- 
national Society of Cardiology system (6), which provides a 
specific code for each component cardiac malformation and 
for specific complexes of lesions. The principal diagnosis is 
allocated in a hierarchical order in the following sequence: 
abnormalities of the cardiac loop, conotruncal and major 
septation defects, atresia and hypoplasia, stenotic lesions, 
septal defects and myocardial lesions. Details of the meth- 
odology concerning the ascertainment of noncardiac anom- 
alies have been described (7). Sociodcmographic, medical 
and family history and environmental exposure data are 
obtained from case and control mothers through a question- 
naire administered during home visits by trained interview- 
ers. The family inquiry obtains information on first degree 
relatives (parents and siblings) of the proband and of each 
parent concerning congenital heart disease. chromosomal 
and other malformations and heritable noncardiac disorders. 
Because the study is population based, the findings represent 
actual frequencies of cardiac and noncardiac anomalies in 
the probands and families in the birth cohort. 
Results 
The presence of genetic noncardiac abnormalities among 
the infants with cardiovascular malformations and among 
control infants is shown in Table I. Chromosomal abnormal- 
Table 2. Connenital Cardiovascular Malformations (CCVMI in First Decree Relatives 
Families With 
Proband Status 
Maternal 
Mother Father Full Siblings Half Siblings 
No. (%I No. (I?c) No. (3%) No. (5) 
cases 
Isolated CCVM (n = 1388) 
With chromosomd abnormality (n - 241) 
With Mendelian abnormality (n = 92) 
With nonsyndromic abnormality (n - 172) 
Total cases 
Controls 
14/13X8 (I Al) 8il388 (0.6) 2ii677 (4.01 l/214 10.5’1 
2:24 I (0.8) I1241 (0.4, Xl41 (I.41 IR9 13.4) 
382 (3.3) 0;3? - 3139 (7.7) O/l3 
11172 (0.6) 2072 (1.2) 3Mb (3.51 21’28 I,7.1 I 
?O/lb3 (1.1) II:1893 (0.6) 35,943 (3.7)” 4:284 (I.41 
41’2328 (0.2) 8:2328 (0.3) I l/l 140 (1.0) 2!343 (0.61 
p i 0.001 ns p < 0.001 ns 
‘41 total a5ected siblings: 4 families with 2 affected siblings: proband with isolated congenital cardiovascular malformations; 1 family with 2 affected siblings: 
proband with Mend&n abnormality; 1 family with 2 alfected siblings: praband with nonsyndromx abnormality. Analyzed by method of Fleiss Jl.. Statistical 
Methods for Rates and Proportions. 2nd ed. New York: John Wiley 81 Sons. 398l:lM?. 
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INHERITANCE OF CARDIAC DEFECT 
ATRIAL SEPTAL DEFECT (A.901 WITH CONDUCTION ABNORMALITIES 
IDlopATHlc HYPERlRoPw amM#mc STENOSIS (IHSS) 
Figure 1. Familial atrial septal defect (ASD) with conduction de- 
fects and idiopathic hypertrophic subaortic stenosis (IHSS). Domi- 
nant genes in these conditions may, respectively, cause alterations 
in the atria1 septum as a result of autoimmunity or affect the 
metabolism of ventricular myocardium. SD = septal defect, type 
unknown. 
ities occurred >lOO times as often among case as among 
control subjects. Mendelian disorders and syndromic asso- 
ciations of 44 types occurred in cases compared with only 6 
types in controls (7). 
Familial occurrence of cardiovascular malformations (Ta- 
ble 2). Information obtained by interview on congenital 
cardiovascular malformations in first degree relatives of case 
and control subjects is available for 1,893 case and 2,328 
control families. There is a highly significant case excess of 
congenital heart disease among mothers and full siblings (p < 
0.001). Evaluation by the associated noncardiac abnormali- 
ties in the probands is impeded by small numbers in the 
subgroups, but valuable information is obtained by detailed 
review of selected pedigrees. These are presented according 
to hypothesized etiologic groups. 
Inheritance of cardiac defect as a single gene effect (Fig. 1). 
Only two families were encountered in which the same 
malformation was transmitted across three generations. 1) In 
one family, atria1 septal defect associated with congenital 
heart block occurred in four adults and three children. The 
Figure 2. Familial concordance in left-sided obstructive lesions 
suggests genetic determination of embryonic blood flow alterations, 
whereas right-sided obstructive lesions may have additional genetic 
or environmental effects. AS = aortic stenosis; ASD = atrial septal 
defect; BicAov = biscuspid aortic valve; C/A = coarctation of 
aorta; HLH = hypoplastic left heart; HRV = hypoplastic right 
ventricle with severe tricuspid and pulmonary stenosis; IND = 
induced abortion; P.atr = pulmonary atresia; PS = pulmonary 
stenosis; SP = spontaneous abortion; VSD = ventricular septal 
defect. Shading indicates the noted genetic disorder. 
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WRTIAL CONCORDANCE OF tXlNOTRUNCAL 
DEFECTS (? FORME FRUSTE) 
Figure 3. Familial aggregations of lesions indicate sub- 
ceptibility to conotruncal maldevelopment in probands 
with pulmonary stenosis (PS) or ventricular septal de- 
fect (VSD). AR = aortic valve regurgitation: T/F = 
tetralogy of Fallot; TGA = transposition of great arter- 
ies: TR = truncus arteriosus; other abbreviations as in 
Figure 2. 
disorder affected both male and female members. 2) Idio- 
pathic hypertrophic subaortic stenosis (asymmetric septal 
hypertrophy) in the mother’s family was reported to have 
also affected more distant relatives, several of whom died 
suddenly, but the disease was not apparent in the 23 year old 
mother of the proband infant. 
Familial obstructive lesions with varying phenotypic sever- 
ity (Fig. 2). A different type of familial concordance was 
noted in families of probands with left-sided obstructive 
lesions: bicuspid aortic valve, aortic stenosis, coarctation of 
the aorta and hypoplastic left heart syndrome occurred in six 
families with no predictable sequence in severity. Among the 
four families with right heart obstructive lesions, isolated 
pulmonary stenosis and atresia occurred in only one sibling 
pair. In each of the other three families, a noncardiac lesion 
of possible etiologic significance was present in the proband. 
However, in some family members, the concordant cardiac 
defect was present without expression of the other disorder. 
Familial evidence of conotruncal defects by partial concor- 
dance (? forme fruste) (Fig. 3). Familial aggregations of 
components of conotruncal malformations with pulmonary 
stenosis or ventricular septal defect in the proband occurred 
in five families: tetralogy of Fallot was present in two parents 
of cases. transposition of the great arteries in a sibling and 
truncus arteriosus in two sibling pairs. 
‘%m ‘#2653 +b6 ‘* 2309 
Endocardial cushion defects in euploid and aneuploid fam- 
ily members (Fig. 4). Among six families with endocardial 
cushion defect in the proband, there were three in which the 
cardiac defect occurred in euploid as well as aneuploid 
members. Two mothers, respectively 22 and 26 years of age at 
the time of the baby’s birth, underwent operation for an 
ostium primum defect in childhood. Each had an infant with a 
complete endocardial cushion defect with trisomy 21. A 
complete endocardial cushion defect occurred in half siblings, 
one with and one without Down’s syndrome. Endocardial 
cushion defect also occurred in a euploid sibling pair. In the 
fifth family, a proband with surgically treated atrial and 
membranous ventricular septal defects had a later ascertained 
sibling with Down’s syndrome and a complete cushion defect. 
In the sixth family, endocardial cushion defect associated 
with pulmonary stenosis occurred in a proband whose mother 
had pulmonary stenosis with a secundum atria1 septal defect. 
Familial noncardiac disorders: heritable blood disorders. 
Evaluation of familial noncardiac disorders indicates further 
complexities in the determination of possible genetic suscep- 
tibility to abnormal cardiac morphogenesis. 
A case-control difierence in major familial blood disorders 
has previously been reported (8). The pedigrees of families 
with major coagulopathies are shown in Figure 5, together 
with a remarkable pedigree observed by Dr. James Manning. 
Von Willebrand’s disease occurred in three case parents: 
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ENDOCMDlAL CIJS-IION DEFECTS IN EUPUIID 
AND ANEUPUMD FAMILY MEMBERS 
w4 ‘#IO47 
Figure 4. Familial aggregation of endocardial cushion 
defect (ECD) in members with and without Down’s 
syndrome indicates heritable genetic effect for cardiac 
malformation. Abbreviations as in Figure 2. Shading 
indicates Down’s syndrome. 
’ + 2360 
‘* 1625 
the mother of an infant with the Williams syndrome, the 
father of an infant with ventricular septal defect and the 
mother of an infant with an atrial septal defect. 
Hemophilia was present in the father and uncle of a 
female carrier infant with transposition of the great arteries 
and in the brother and two cousins of a baby with atrioven- 
tricular canal and trisomy 21. The latter infant had a bleeding 
tendency, but a factor VIII deficiency was not confirmed. In 
Dr. Manning’s observed family, three brothers had hemo- 
philia, one with an atrial septal defect, and one brother had 
transposition of the great arteries without diagnosed coagu- 
lopathy. 
Discussion 
Preliminary evaluation of the descriptive epidemiology of 
cardiovascular malformations raises new etiologic questions 
as population-based data extend the knowledge derived from 
clinical studies. 
The familial occurrence of atrial septal defect with a 
conduction abnormality. This malformation was recognized 
as a syndrome of clinical and genetic importance by Eman- 
uel et al. (9), and further reports of affected families (10,ll) 
led McKusick (12) to describe this entity (McKusick code 
10890) as “a specific form of atrial septal defect.” The 
occurrence of a sinus venosus defect with bradyarrhythmia 
(13) in a mother and her son and daughter suggested to other 
investigators a genetically induced tissue alteration. 
The evolution of a mild conduction abnormality to com- 
plete heart block, as seen in our family and in the reports of 
others, is not unlike that observed in familial congenital 
heart block (McKusick code 14040). It seems reasonable to 
hypothesize that atrial septal defect with conduction abnor- 
mality is a distinct entity with a different histopathologic 
origin from that of uncomplicated atrial septal defects. A 
possible role of autoimmunity and connective tissue disor- 
ders must be considered in view of the association of 
congenital heart block and maternal lupus erythematosus 
(14-16). Information regarding the cellular pathology of 
atrial septal defects with associated conduction lesions could 
help to clarify the etiologic distinctions. 
Hypertrophic cardiomyopathy. In contrast to a lack of 
microscopic descriptions of atrial lesions, extensive histo- 
pathologic and metabolic data have been accumulated on 
ventricular myocardium regarding the origin of idiopathic 
hypertrophic subaortic stenosis (17), but the mechanism of 
the inherited risk factors has not yet been defined. 
Left heart lesions. The Baltimore-Washington Infant 
Study data suggest that certain cardiac morphologic pheno- 
types form seemingly homogeneous groups according to 
presumed developmental mechanisms, whereas other mech- 
anistic subgroups are etiologically heterogeneous. Left heart 
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VON WlLLESR8Nd.S HEMOPnlLlA 
SPHEROCYTOSIS 
OTHER INVESTIGATOR 
HEMOPHILIA 
. 
99 
lesions that are presumed to be due to altered embryonic 
blood flow (18) occur in families in various degrees of 
severity, thus suggesting that genetic factors predispose to 
left-sided flow alterations, but we have no knowledge of the 
cause of these flow lesions. Studies of recurrence rates (19) 
and segregation patterns (20) have suggested a genetic lia- 
bility consistent with a single gene effect. 
Right-sided obstructive lesions and membranous ventricu- 
lar septal defects. Both of these malformations, also pre- 
sumed to be due to altered flow, appear to be developmen- 
tally heterogeneous as they occur in familial combinations 
with conotruncal malformations. This partial concordance 
was described as a “conotruncal susceptibility” by Corone 
et al. (21) and parallels the spectrum of conotruncal lesions 
obtained experimentally in Keeshond dogs (22) as “forme 
fruste” manifestations of conotruncal abnormalities. 
Pulmonary stenosis. The association of pulmonary steno- 
sis in the mother of an infant with Noonan’s syndrome and 
pulmonary stenosis could be explained as a genetic lesion if 
the mother had unrecognized Noonan’s syndrome. This 
would, however, also mean that inapparent syndromes 
might be present in other cases of simple pulmonary steno- 
sis. Similar considerations apply to the family with fron- 
tometaphyseal dysplasia in which both the cardiac and 
noncardiac lesions occurred together in the proband, but 
each type of lesion also occurred alone in a first degree 
Figure 5. Heritable blood disorders in family members of infants 
with cardiovascular malformations in case families but none in 
control families suggests etiologic relation. D = deaf; M = murmur; 
other abbreviations as in Figures 2 and 3. Shading indicates the 
noted blood disorder: the solid dot indicates the carrier. We thank 
Dr. James Manning for his permission to show the pedigree ob- 
served by him. 
relative, suggesting a probable single etiology. The occur- 
rence of pulmonary stenosis and cataracts in another 
proband raises the question of rubella syndrome, although a 
previous sibling also had the same cardiac disorder. 
Endocardial cushion defect. The familial association of 
endocardial cushion defects in euploid and aneuploid individ- 
uals was noted in a previous publication (23). Recent morpho- 
genetic studies (24) demonstrated biochemical alterations 
with increased cellular adhesiveness in patients with Down’s 
syndrome. On the basis of this work, Boughman et al. (23) 
proposed that specific alleles responsible for these changes 
may be segregating in some families of patients with Down’s 
syndrome. Recently, Ardinger et al. (25) reported abnormal- 
ities in transforming growth factor alpha in euploid and 
aneuploid cases of endocardial cushion defect, a finding that 
may lead to answers regarding the nature of the inherited 
abnormality. 
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Associated blood disorders. The association of cardiac 
and blood disorders was previously reported from the Bal- 
timore-Washington Infant Study (8) together with a literature 
review of hematologic abnormalities in cyanotic and acya- 
notic patients with congenital heart disease. In addition to 
the two probands with transposition in this study, two other 
cases of hemophilia and transposition have been reported 
(26). 
The coincidence oj’transposition qf the great arteries and 
hemophilia is notable because, by virtue of the rarity of each 
condition (about 2 : lO,OOO), this association could be cx- 
petted to occur by chance in only I of 4 million births. 
Knowledge of several such families raises the hypothesis 
that genetic errors of endothelial cells may constitute an 
initiating susceptibility to cardiac maldevelopment with pos- 
sible variability in expression (27,28). The recent great 
expansion of knowledge on the role of endothelial ceils in 
coagulation, growth factor synthesis and microvascular de- 
velopment, as described by Jaffe (29), illuminates the likeli- 
hood of probable important effects also in embryonic life. 
Conclusions. The epidemiologic evaluation of cardiovas- 
cular malformations as described in this report of familial 
aggregations emphasizes the questions of biologic impor- 
tance: what are the inheritedfactors that affect morphogen- 
esis? 
Our description of a population-based case group sug- 
gests the need for clarification of the following possibilities: 
1) atria1 tissue alterations associated with autoimmunity; 2) 
alterations of myocardial cell metabolism; 3) causes of 
embryonic blood flow variations; 4) incomplete and variable 
phenotypic expression of genetic disorders; 5) forme fruste 
expressions of conotruncal malformations; 6) biochemical 
alterations affecting endocardial cushion development; and 
7) genetic errors of endothelial ceil functions affecting coag- 
ulation and vascular growth. 
Future studies of familial patterns of inheritance should 
attempt to evaluate cellular, immunologic and mechanistic 
processes and lead to a biologic recategorization of cardio- 
vascular malformations into etiologically related entities. 
Coordinated multidisciplinary studies, so successful in adult 
cardiology, would be promising in the elucidation of etio- 
logic risk factors of cardiovascular maldevelopment. 
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